Long Term Care Journal
Tuesday, March 19, 2019
FDA approves first treatment for post-partum depression - FDA Press Releases
FDA approves Zulresso (brexanolone), the first drug for post-partum depression
from Food and Drug Administration--Press Releases https://ift.tt/2Y7rl6F
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment